Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study

Social Psychiatry and Psychiatric Epidemiology

Volumn 50, Issue 8, 2015, Pages 1267-1276

  Nesvåg, Ragnar ^a   Knudsen, Gun Peggy ^a   Bakken, Inger Johanne ^a   Høye, Anne ^a,b   Ystrom, Eivind ^a   Surén, Pål ^a   Reneflot, Anne ^a   Stoltenberg, Camilla ^a,c   Reichborn Kjennerud, Ted ^a,d  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b Center of Clinical Documentation and Evaluation   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Bipolar disorder; Depression; Registry; Schizophrenia; Substance related disorders

Indexed keywords

ADOLESCENT; ADULT; ALCOHOL-RELATED DISORDERS; BIPOLAR DISORDER; COMORBIDITY; COMPARATIVE STUDY; DEPRESSIVE DISORDER; FEMALE; HUMAN; MALE; MIDDLE AGED; MOOD DISORDERS; NORWAY; ONSET AGE; PREVALENCE; PSYCHOTIC DISORDERS; REGISTER; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; ALCOHOL-RELATED DISORDERS; BIPOLAR DISORDER; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; NORWAY; PREVALENCE; PSYCHOTIC DISORDERS; REGISTRIES; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84938424211     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-015-1025-2     Document Type: Article

References (37)

1. Negrete JC (2003) Clinical aspects of substance abuse in persons with schizophrenia. Can J Psychiatry 48:14–21
2. Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K (2004) Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res 67:157–166
3. Turkington A, Mulholland CC, Rushe TM, Anderson R, McCaul R, Barrett SL, Barr RS, Cooper SJ (2009) Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psychiatry 195:242–248
4. Cantor-Graae E, Nordström LG, Mcneil TF (2001) Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 48:69–82
5. Opsal A, Clausen T, Kristensen O, Elvik I, Joa I, Larsen TK (2011) Involuntary hospitalization of first-episode psychosis with substance abuse during a 2-year follow-up. Acta Psychiatr Scand 124:198–204
6. Kavanagh DJ, McGrath J, Saunders JB, Dore G, Clark D (2002) Substance misuse in patients with schizophrenia: epidemiology and management. Drugs 62:743–755
7. Lagerberg TV, Andreassen OA, Ringen PA, Berg AO, Larsson S, Agartz I, Sundet K, Melle I (2010) Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study. BMC Psychiatry 10:9. doi:10.1186/1471-244X-10-9
8. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) Study. JAMA 264:2511–2518
9. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC (1996) Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry 53:1022–1031
10. Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Ruan WJ, Huang B (2005) Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry 66:1205–1215
11. Hasin DS, Goodwin RD, Stinson FS, Grant BF (2005) Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on alcoholism and related conditions. Arch Gen Psychiatry 62:1097–1106
12. Larsen TK, Melle I, Auestad B, Friis S, Haahr U, Johannessen JO, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan TH (2006) Substance abuse in first-episode non-affective psychosis. Schizophr Res 88:55–62
13. Nesvåg R, Lange EH, Faerden A, Barrett EA, Emilsson B, Ringen PA, Andreassen OA, Melle I, Agartz I (2010) The use of screening instruments for detecting alcohol and other drug use disorders in first-episode psychosis. Psychiatry Res 177:228–234
14. Ringen PA, Melle I, Birkenaes AB, Engh JA, Faerden A, Jónsdóttir H, Nesvåg R, Vaskinn A, Friis S, Larsen F, Opjordsmoen S, Sundet K, Andreassen OA (2008) Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study. Acta Psychiatr Scand 117:133–138
15. Neale MC, Kendler KS (1995) Models of comorbidity for multifactorial disorders. Am J Hum Genet 57:935–953
16. Kessler RC, Birnbaum H, Demler O, Falloon IR, Gagnon E, Guyer M, Howes MJ, Kendler KS, Shi L, Walters E, Wu EQ (2005) The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol Psychiatry 58:668–676
17. Koskinen J, Löhönen J, Koponen H, Isohanni M, Miettunen J (2009) Prevalence of alcohol use disorders in schizophrenia—a systematic review and meta-analysis. Acta Psychiatr Scand 120:85–96
18. Koskinen J, Löhönen J, Koponen H, Isohanni M, Miettunen J (2010) Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 36:1115–1130
19. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC (2007) Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 64:543–552
20. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z (2011) Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative. Arch Gen Psychiatry 68:241–251
21. Cerullo MA, Strakowski SM (2007) The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy 2:29. doi:10.1186/1747-597X-2-29
22. Kringlen E, Torgersen S, Cramer V (2001) A Norwegian psychiatric epidemiological study. Am J Psychiatry 158:1091–1098
23. Kringlen E, Torgersen S, Cramer V (2006) Mental illness in a rural area: a Norwegian psychiatric epidemiological study. Soc Psychiatry Psychiatr Epidemiol 41:713–719
24. Ringen PA, Lagerberg TV, Birkenaes AB, Engn J, Faerden A, Jónsdottir H, Nesvåg R, Friis S, Opjordsmoen S, Larsen F, Melle I, Andreassen OA (2008) Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder. Psychol Med 38:1241–1249
25. Di Forti M, Morrison PD, Butt A, Murray RM (2007) Cannabis use and psychiatric and cognitive disorders: the chicken or the egg? Curr Opin Psychiatry 20:228–234
26. Di Forti M, Sallis H, Allegri F, Trotta A, Ferraro L, Stilo SA, Marconi A, La Cascia C, Reis Marques T, Pariante C, Dazzan P, Mondelli V, Paparelli A, Kolliakou A, Prata D, Gaughran F, David AS, Morgan C, Stahl D, Khondoker M, Maccabe JH, Murray RM (2014) Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull 40:1509–1517. doi:10.1093/schbul/sbt181
27. Arseneault L, Cannon M, Witton J, Murray RM (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184:110–117
28. Chambers RA, Krystal JH, Self DW (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50:71–83
29. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8–19
30. Berkson J (1946) Limitations of the application of fourfold table analysis to hospital data. Biom Bull 2:47–53
31. Newman DL, Moffitt TE, Caspi A, Silva PA (1998) Comorbid mental disorders: implications for treatment and sample selection. J Abnorm Psychol 107:305–311
32. Oiesvold T, Nivison M, Hansen V, Skre I, Ostensen L, Sørgaard KW (2013) Diagnosing comorbidity in psychiatric hospital: challenging the validity of administrative registers. BMC Psychiatry 13:13. doi:10.1186/1471-244X-13-13
33. Øiesvold T, Nivison M, Hansen V, Sørgaard KW, Østensen L, Skre I (2012) Classification of bipolar disorder in psychiatric hospital. a prospective cohort study. BMC Psychiatry 12:13–14. doi:10.1186/1471-244X-12-13
34. Jakobsen KD, Frederiksen JN, Hansen T, Jansson LB, Parnas J, Werge T (2005) Reliability of clinical ICD-10 schizophrenia diagnoses. Nord J Psychiatry 59:209–212
35. Dalman C, Broms J, Cullberg J, Allebeck P (2002) Young cases of schizophrenia identified in a national inpatient register—are the diagnoses valid? Soc Psychiatry Psychiatr Epidemiol 37:527–531
36. Ekholm B, Ekholm A, Adolfsson R, Vares M, Osby U, Sedvall GC, Jönsson EG (2005) Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry 59:457–464
37. Pihlajamaa J, Suvisaari J, Henriksson M, Heilä H, Karjalainen E, Koskela J, Cannon M, Lönnqvist J (2008) The validity of schizophrenia diagnosis in the Finnish Hospital Discharge Register: findings from a 10-year birth cohort sample. Nord J Psychiatry 62:198–203